Clinical Trials Browser

Phase 2 × quizartinib × 1 year × Clear all

NCT06824168 2025-12-04

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT04107727 2025-09-02

Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute